These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3857041)

  • 1. delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition.
    Narumiya S; Fukushima M
    Biochem Biophys Res Commun; 1985 Mar; 127(3):739-45. PubMed ID: 3857041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
    Narumiya S; Fukushima M
    J Pharmacol Exp Ther; 1986 Nov; 239(2):500-5. PubMed ID: 3772804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antineoplastic action of prostaglandin D2--effect of PGD2 on proliferation of L1210 leukemic cells in culture].
    Fukushima M; Kato T; Ota K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):159-60. PubMed ID: 6964030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei.
    Narumiya S; Ohno K; Fukushima M; Fujiwara M
    J Pharmacol Exp Ther; 1987 Jul; 242(1):306-11. PubMed ID: 3302206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma.
    Kikawa Y; Narumiya S; Fukushima M; Wakatsuka H; Hayaishi O
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1317-21. PubMed ID: 6584883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycloheximide reduces PGD2 or delta 12-PGJ2 cytotoxicity on NCG cells.
    Shimizu Y; Todo S; Imashuku S
    Prostaglandins; 1986 Oct; 32(4):517-25. PubMed ID: 3099333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro effects of antineoplastic prostaglandins on human leukemic cell growth and normal myelopoiesis.
    Tsao CJ; Ozawa K; Hosoi T; Urabe A; Takaku F
    Leuk Res; 1986; 10(5):527-32. PubMed ID: 3012210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of cell cycle by metabolites of prostaglandin D2 through a non-cAMP mediated mechanism.
    Hughes-Fulford M; Fukushima M
    Life Sci Adv Exp Clin Endocrinol; 1993; 12():57-64. PubMed ID: 11539936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active transport and cellular accumulation of cyclopentenone prostaglandins: a mechanism of prostaglandin-induced growth inhibition.
    Narumiya S; Fukushima M
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():972-5. PubMed ID: 2960214
    [No Abstract]   [Full Text] [Related]  

  • 10. On the identification and biological properties of prostaglandin J2.
    Mahmud I; Smith DL; Whyte MA; Nelson JT; Cho D; Tokes LG; Alvarez R; Willis AL
    Prostaglandins Leukot Med; 1984 Nov; 16(2):131-46. PubMed ID: 6597446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: correlation with prostaglandin E2-induced growth inhibition.
    Ohno K; Fujiwara M; Fukushima M; Narumiya S
    Biochem Biophys Res Commun; 1986 Sep; 139(2):808-15. PubMed ID: 3464277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of PGD2 and 9-deoxy-delta 9-PGD2 on colony formation of murine osteosarcoma cells.
    Tanaka H; Yamamuro T; Matsumoto M; Kotoura Y; Tanaka C
    Prostaglandins; 1985 Jul; 30(1):167-74. PubMed ID: 3863195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the proliferation of transformed epidermal cells in culture by various prostaglandins.
    Ikai K; Ujihara M; Kashihara M; Fukushima M
    J Invest Dermatol; 1987 Jul; 89(1):69-72. PubMed ID: 2439606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
    Narumiya S; Ohno K; Fujiwara M; Fukushima M
    J Pharmacol Exp Ther; 1986 Nov; 239(2):506-11. PubMed ID: 3772805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP-mediated inhibition of cell growth by prostaglandin D2 in a fibroblastic cell line (EBTr).
    Okuda-Ashitaka E; Negishi M; Sugama K; Hatanaka M; Ito S
    Eicosanoids; 1990; 3(4):213-8. PubMed ID: 1705811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell growth inhibition by prostaglandins and its action mechanism].
    Narumiya S; Kato T; Fukushima M
    Seikagaku; 1985 Jul; 57(7):578-93. PubMed ID: 3906000
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of prostaglandin D2 on the growth of mouse glioma].
    Nakagawa Y; Suzuki K; Ueda S; Hirakawa K; Nishino H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2074-81. PubMed ID: 3459395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells.
    Sakai T; Yamaguchi N; Kawai K; Nishino H; Iwashima A
    Cancer Lett; 1983 Jan; 17(3):289-94. PubMed ID: 6572553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture.
    Bhuyan BK; Adams EG; Badiner GJ; Li LH; Barden K
    Cancer Res; 1986 Apr; 46(4 Pt 1):1688-93. PubMed ID: 3456266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kinetic studies of PGD2 cytotoxicity on the in vitro growth of human neuroblastoma.
    Todo S; Hashida T; Shimizu Y; Imashuku S; Takamatsu T; Fujita S
    Prostaglandins Leukot Med; 1986 Jul; 23(1):55-65. PubMed ID: 3016753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.